Spain In Vitro Diagnostics Quality Control Market Size & Outlook

The in vitro diagnostics quality control market in Spain is expected to reach a projected revenue of US$ 36.0 million by 2030. A compound annual growth rate of 3.8% is expected of Spain in vitro diagnostics quality control market from 2024 to 2030.
Revenue, 2023 (US$M)
$27.7
Forecast, 2030 (US$M)
$36.0
CAGR, 2024 - 2030
3.8%
Report Coverage
Spain

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Spain in vitro diagnostics quality control market, 2018-2030 (US$M)

Spain in vitro diagnostics quality control market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

Spain in vitro diagnostics quality control market highlights

  • The Spain in vitro diagnostics quality control market generated a revenue of USD 27.7 million in 2023 and is expected to reach USD 36.0 million by 2030.
  • The Spain market is expected to grow at a CAGR of 3.8% from 2024 to 2030.
  • In terms of segment, controls was the largest revenue generating product in 2023.
  • Calibrators is the most lucrative product segment registering the fastest growth during the forecast period.


In vitro diagnostics quality control market data book summary

Market revenue in 2023USD 27.7 million
Market revenue in 2030USD 36.0 million
Growth rate3.8% (CAGR from 2023 to 2030)
Largest segmentControls
Fastest growing segmentCalibrators
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationControls, Calibrators
Key market players worldwideSiemens Healthineers AG ADR, Abbott Laboratories, Bio-Rad Laboratories Inc, Danaher Corp, Roche Holding AG ADR, Sysmex Corp, QuidelOrtho Corp, Thermo Fisher Scientific Inc, BD, Merck KGaA, Qiagen NV, Hologic Inc, Bio-Techne Corp, Randox, Helena Laboratories, Seracare Life Sciences, Fortress Diagnostics, Microbiologics, TRINA BIOREACTIVES, Cone Bioproducts, Biorex Food Diagnostics


Other key industry trends

  • In terms of revenue, Spain accounted for 2.2% of the global in vitro diagnostics quality control market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, Germany in vitro diagnostics quality control market is projected to lead the regional market in terms of revenue in 2030.
  • Spain is the fastest growing regional market in Europe and is projected to reach USD 36.0 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

In Vitro Diagnostics Quality Control Market Scope

In Vitro Diagnostics Quality Control Market Companies

Name Profile # Employees HQ Website
Biorex Food Diagnostics View profile 101-250 Antrim, Antrim, United Kingdom, Europe https://biorexfooddiagnostics.com
Cone Bioproducts View profile 11-50 Seguin, Texas, United States, North America https://www.conebio.com
TRINA BIOREACTIVES View profile 11-50 Nänikon, Zurich, Switzerland, Europe http://www.trinabio.com
Microbiologics View profile 1-10 Saint Cloud, Minnesota, United States, North America http://www.microbiologics.com/
Fortress Diagnostics View profile 51-100 Antrim, Antrim, United Kingdom, Europe https://www.fortressdiagnostics.com
Seracare Life Sciences View profile 51-100 Milford, Massachusetts, United States, North America http://www.seracare.com
Helena Laboratories View profile 501-1000 Beaumont, Texas, United States, North America https://www.helena.com/
Randox View profile 1001-5000 Crumlin, Antrim, United Kingdom, Europe http://www.randox.com
BD View profile 10001+ Franklin Lakes, New Jersey, United States, North America https://www.bd.com
Bio-Techne Corp View profile 3050 614 McKinley Place N.E., Minneapolis, MN, United States, 55413 https://www.bio-techne.com
Sysmex Corp View profile 10448 1-5-1 Wakinohara-Kaigandori, Chuo-ku, Hyogo Prefecture, Kobe, Japan, 6510073 http://www.sysmex.co.jp
Hologic Inc View profile 6990 250 Campus Drive, Marlborough, MA, United States, 01752 http://www.hologic.com
Qiagen NV View profile 5900 Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL https://www.qiagen.com
Bio-Rad Laboratories Inc View profile 8030 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 https://www.bio-rad.com
QuidelOrtho Corp View profile 7100 9975 Summers Ridge Road, San Diego, CA, United States, 92121 https://www.quidelortho.com
Danaher Corp View profile 63000 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 https://www.danaher.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
Siemens Healthineers AG ADR View profile 71400 Siemensstr. 3, Forchheim, BY, Germany, 91301 https://www.siemens-healthineers.com
Abbott Laboratories View profile 114000 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 https://www.abbottinvestor.com
Merck KGaA View profile 62345 Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 https://www.emdgroup.com
Roche Holding AG ADR View profile 103605 Grenzacherstrasse 124, Basel, Switzerland, 4070 https://www.roche.com

Spain in vitro diagnostics quality control market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in vitro diagnostics quality control market will help companies and investors design strategic landscapes.


Controls was the largest segment with a revenue share of 48.38% in 2023. Horizon Databook has segmented the Spain in vitro diagnostics quality control market based on controls, calibrators covering the revenue growth of each sub-segment from 2018 to 2030.


Spain has an advanced healthcare infrastructure along with a stringent regulatory framework, which is expected to act as a major driver for the growth of quality control testing for IVDs. Moreover, the prevalence of antimicrobial resistance and other chronic diseases that require constant monitoring, such as hyperlipidemia, is also rising in Spain. 

As per the Journal of Clinical Microbiology, quality control is essential to diagnose & identify diseases accurately, as diagnosis is the first step to controlling and testing diseases. The lab is one of the leading providers of quality control solutions in the country. 

Spanish national accreditation body grants accreditation to only the laboratories that participate in regular proficiency testing & maintain their quality control norms, steering the growth of the IVDs quality control market in the country.

Reasons to subscribe to Spain in vitro diagnostics quality control market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Spain in vitro diagnostics quality control market databook

  • Our clientele includes a mix of in vitro diagnostics quality control market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Spain in vitro diagnostics quality control market , including forecasts for subscribers. This country databook contains high-level insights into Spain in vitro diagnostics quality control market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Spain in vitro diagnostics quality control market size, by product, 2018-2030 (US$M)

Spain In Vitro Diagnostics Quality Control Market Outlook Share, 2023 & 2030 (US$M)

Spain in vitro diagnostics quality control market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online